Safety of long-term (LT) treatment (tmt) of chemotherapy (chemo)-naive metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with abiraterone acetate plus prednisone (AA plus P) for ≥ 4 years (yrs)

被引：20

作者：

Carles, J. ^{[1
]}

Davis, I. ^{[2
]}

De Bono, J. S. ^{[3
,4
]}

Fizazi, K. ^{[5
]}

Gerritsen, W. ^{[6
]}

Rathkopf, D. E. ^{[7
,8
]}

Ryan, C. J. ^{[9
]}

Saad, F. ^{[10
]}

Steuber, T. ^{[11
]}

Wilding, G. ^{[12
]}

Park, Y. C. ^{[13
]}

Charnas, R. ^{[14
]}

De Porre, P. ^{[15
]}

Van Poppel, H. ^{[16
]}

机构：

[1] Vall dHebron Univ Hosp, Inst Oncol, Oncol, Barcelona, Spain

[2] Monash Univ, Eastern Hlth Clin Sch, Med, Box Hill, Clayton, Vic, Australia

[3] Inst Canc Res, Div Canc Therapeut Clin Studies, London, England

[4] Royal Marsden Hosp, London, England

[5] Inst Gustave Roussy, Canc Med, Villejuif, France

[6] Radboud Univ Nijmegen, Med Ctr Nijmegen, Med Oncol, Nijmegen, Netherlands

[7] Mem Sloan Kettering Canc Ctr, Oncol & Internal Med, 1275 York Ave, New York, NY 10021 USA

[8] Weill Cornell Med Coll, New York, NY USA

[9] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Hematol Oncol, Med, San Francisco, CA 94143 USA

[10] Univ Montreal, Surg, Montreal, PQ, Canada

[11] Univ Hosp Hamburg Eppendorf, Martini Clini, Med, Hamburg, Germany

[12] Univ Texas MD Anderson Canc Ctr, Genitourinary Med Oncol, Houston, TX 77030 USA

[13] Janssen Res & Dev, Biostats Oncol, Raritan, NJ USA

[14] Janssen Res & Dev, WC Oncol, Los Angeles, CA USA

[15] Janssen Res & Dev, Clin Oncol, Beerse, Belgium

[16] Katholieke Univ Leuven, Univ Hosp, Urol, Leuven, Belgium

来源：

关键词：

D O I：

10.1093/annonc/mdw372.24

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

740P

引用

页数：1